US FDA, Actavis, Salix, prevail on Norwich’s APA case over ANDA tentative approval
Litigation by Norwich Pharmaceuticals over the US Food and Drug Administration’s decision to grant its application for generic rifaximin only tentative approval cratered last week when a District of Columbia federal...To view the full article, register now.
Already a subscriber? Click here to view full article